Masanori Nakahara

Serum Agalactosyl IgG Predicts Hepatocellular Carcinoma and All‐Cause Mortality After SVR in Advanced Chronic Hepatitis C

Daisuke Sakon, Jumpei Kondo, Yuki Tahata, Hayato Hikita et autres

jp (code pays fourni par la source)

Comparison of outcomes of second-line durvalumab plus tremelimumab versus lenvatinib following first-line atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma

Chinatsu Nishioka, Yuki Tahata, Kazuki Maesaka, Machiko Kai et autres

jp (code pays fourni par la source)

On-treatment viral factors affect subsequent hepatitis B surface antigen seroclearance in patients treated with nucleos(t)ide analogs for > 10 years

Tetsuya Hosaka, Hayato Hikita, Yuki Tahata, Ryoko Yamada et autres

jp (code pays fourni par la source)

Impact of Treatment Response to Anticoagulant Therapy on Liver‐Related Events in Patients With Cirrhosis and Portal Vein Thrombosis

Atsushi Maeda, Yuki Tahata, Hayato Hikita, Hisashi Ishida et autres

jp (code pays fourni par la source)

Comparison of outcomes of second-line durvalumab plus tremelimumab and lenvatinib following first-line atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma

Chinatsu Nishioka, Yuki Tahata, Kazuki Maesaka, Machiko Kai et autres

jp (code pays fourni par la source)

Comparative analysis of lenvatinib use after atezolizumab plus bevacizumab versus lenvatinib as first-line therapy in unresectable hepatocellular carcinoma

Kazuki Maesaka, Hayato Hikita, Yuki Tahata, Machiko Kai et autres

jp (code pays fourni par la source)

Hypertension as an Adverse Event Potentially Impacting the Therapeutic Efficacy of Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma

Kazuki Maesaka, Hayato Hikita, Machiko Kai, Yuki Tahata et autres

jp (code pays fourni par la source)

The Risk of Developing Hepatocellular Carcinoma Persists in Chronic Hepatitis B Patients Even After the Long‐Term Administration of Nucleos(t)ide Analogs

Kazuhiro Murai, Hayato Hikita, Ryoko Yamada, Yuki Nishimura et autres

jp (code pays fourni par la source)

Effectiveness of tacrolimus therapy in refractory ulcerative colitis compared to infliximab with propensity score matching

Takeo Yoshihara, Takahiro Amano, Shinichiro Shinzaki, Yuri Tsujii et autres

jp (code pays fourni par la source)

Efficacy of prophylactic clip closure in reducing the risk of delayed bleeding after colorectal endoscopic submucosal dissection in patients on anticoagulant therapy: Multicenter prospective study

Hideharu Ogiyama, Minoru Kato, Shinjiro Yamaguchi, Takashi Kanesaka et autres

jp (code pays fourni par la source)

EP143 LONG-TERM OUTCOMES OF TACROLIMUS VS. ANTI-TUMOR NECROSIS FACTOR AGENTS IN THE TREATMENT FOR ULCERATIVE COLITIS: A MULTI-INSTITUTIONAL, PROPENSITY SCORE MATCHING COMPARATIVE EFFICACY STUDY

Takuya Yamada, Takeo Yoshihara, Takahiro Amano, Yasushi Sakakibara et autres

Diagnostic value of endoscopic ultrasonography for the depth of gastric cancer suspected of submucosal invasion: a multicenter prospective study

Yoshiki Tsujii, Yoshito Hayashi, Ryu Ishihara, Shinjiro Yamaguchi et autres

jp (code pays fourni par la source)